Terms: = Pancreatic cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
104 results:
1. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract] [Full Text] [Related]
2. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Yang Y; Li L; Xu Y; Ouyang J; Zhou Y; Ye F; Huang Z; Zhang W; Zhou A; Zhao X; Cai J; Wang Y; Zhou J; Zhao H
Radiol Med; 2024 Feb; 129(2):188-201. PubMed ID: 38180570
[TBL] [Abstract] [Full Text] [Related]
3. The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis.
Qi YQ; Xiong F; Chen YJ
Pathol Res Pract; 2023 Dec; 252():154919. PubMed ID: 37939428
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract] [Full Text] [Related]
5. Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
Xu Y; Yang Y; Ouyang J; Zhou Y; Li L; Ye F; Yang H; Huang Z; Zhou A; Zhang W; Zhou J; Zhao X; Zhao H
Eur Radiol; 2024 Apr; 34(4):2244-2255. PubMed ID: 37740779
[TBL] [Abstract] [Full Text] [Related]
6. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.
Yang T; Wang N; Wang F; Liu H; Shen F; Lv G
BMJ Open; 2023 Sep; 13(9):e076467. PubMed ID: 37723113
[TBL] [Abstract] [Full Text] [Related]
7. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrence.
Nishimagi A; Kobayashi M; Sugimoto K; Kofunato Y; Sato N; Haga J; Ishigame T; Kimura T; Kenjo A; Kobayashi Y; Hashimoto Y; Marubashi S; Chiba H
Clin Exp Med; 2023 Dec; 23(8):4985-4995. PubMed ID: 37285077
[TBL] [Abstract] [Full Text] [Related]
9. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract] [Full Text] [Related]
10. The Japanese 5-5-500 Rule Predicts prognosis of Hepatocellular Carcinoma After Hepatic Resection.
Takishima T; Haruki K; Taniai T; Furukawa K; Horiuchi T; Onda S; Yanagaki M; Shirai Y; Hamura R; Ikegami T
Anticancer Res; 2023 Apr; 43(4):1623-1629. PubMed ID: 36974785
[TBL] [Abstract] [Full Text] [Related]
11. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of the Sequential Treatment of Unresectable Hepatocellular Carcinoma Using Lenvatinib.
Nakagawa D; Komatsu S; Yano Y; Kido M; Kuramitsu K; Yamamoto A; Omiya S; Shimura Y; Goto T; Yanagimoto H; Toyama H; Ueda Y; Kodama Y; Fukumoto T
Anticancer Res; 2023 Feb; 43(2):911-918. PubMed ID: 36697097
[TBL] [Abstract] [Full Text] [Related]
13. The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and prognosis of HCC in Egyptian Patients.
Abdelsattar S; Sweed D; Kamel HFM; Kasemy ZA; Gameel AM; Elzohry H; Ameen O; Elgizawy EI; Sallam A; Mosbeh A; Abdallah MS; Khalil FO; Al-Amodi HS; El-Hefnway SM
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671388
[TBL] [Abstract] [Full Text] [Related]
14. The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular Carcinoma.
Ota M; Komeda K; Iida H; Ueno M; Kosaka H; Nomi T; Tanaka S; Nakai T; Hokutou D; Matsumoto M; Hirokawa F; Lee SW; Kaibori M; Kubo S
Ann Surg Oncol; 2023 May; 30(5):2807-2815. PubMed ID: 36641514
[TBL] [Abstract] [Full Text] [Related]
15. Identifying hepatocellular carcinoma patients with survival benefits from surgery combined with chemotherapy: based on machine learning model.
Hu J; Gong N; Li D; Deng Y; Chen J; Luo D; Zhou W; Xu K
World J Surg Oncol; 2022 Dec; 20(1):377. PubMed ID: 36451200
[TBL] [Abstract] [Full Text] [Related]
16. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.
Xue J; Ge P; Wu Y
Clin Exp Med; 2023 Sep; 23(5):1515-1536. PubMed ID: 36342581
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative aspartate aminotransferase to albumin ratio correlates with tumor characteristics and predicts outcome of hepatocellular carcinoma patients after curative hepatectomy: a multicenter study.
Peng W; Shen J; Dai J; Leng S; Xie F; Zhang Y; Ran S; Sun X; Wen T
BMC Surg; 2022 Aug; 22(1):307. PubMed ID: 35945520
[TBL] [Abstract] [Full Text] [Related]
19. TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma.
Li Y; Wu J; Li E; Xiao Z; Lei J; Zhou F; Yin X; Hu D; Mao Y; Wu L; Wenjun L
Cancer Biol Ther; 2022 Dec; 23(1):439-445. PubMed ID: 35921289
[TBL] [Abstract] [Full Text] [Related]
20. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
[Next]
